nicotinic acetylcholine receptor inhibitors (Promiliad Biopharma)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenicotinic acetylcholine receptor inhibitors (Promiliad Biopharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNicotinic receptors antagonists
TargetsNicotinic receptors
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPromiliad Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPromiliad Biopharma Inc
Active IndicationsN/A
Inactive IndicationsTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksN/A